The news on Novartis
ShareThere has been 34 news on Novartis in the past from 8 different sources and amongst 2 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
Novartis agrees $3bn deal to buy heart drug biotech from Blackstone
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
Siemens Healthineers boosts cancer imaging with EUR200mn Novartis deal
Novartis warns prostate cancer drug price will remain high
Novartis Raises Guidance as Key Drugs Boost Sales
Stocks making the biggest premarket moves: General Motors, GE Aerospace, Novartis, JetBlue and more
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
Novartis Ups Guidance on Profit, Sales Growth
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H
Novartis Earnings, Outlook Fall Short
Novartis backed away from its pursuit of Cytokinetics, putting a damper on the prospects of a deal for the promising heart-drug developer.
Novartis Pursuit of Cytokinetics Cools
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as big pharma companies continue buying fast-growing biotechs to replenish pipelines.
Novartis in Advanced Talks to Buy Cytokinetics
Sections
The coverage spreads amongst 2 sections:
Sources
There has been 8 news sources reporting on this, including: The Wall Street Journal (44%), CNBC News (21%), Financial Times (12%), Times of India (9%), Bloomberg (6%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license
